KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Work In Process (2016 - 2025)

Charles River Laboratories International (CRL) has 16 years of Work In Process data on record, last reported at $200.6 million in Q4 2025.

  • For Q4 2025, Work In Process fell 5.38% year-over-year to $200.6 million; the TTM value through Dec 2025 reached $200.6 million, down 5.38%, while the annual FY2025 figure was $200.6 million, 5.38% down from the prior year.
  • Work In Process reached $200.6 million in Q4 2025 per CRL's latest filing, down from $210.9 million in the prior quarter.
  • Across five years, Work In Process topped out at $228.5 million in Q3 2023 and bottomed at $28.3 million in Q2 2021.
  • Average Work In Process over 5 years is $174.9 million, with a median of $211.4 million recorded in 2024.
  • Peak YoY movement for Work In Process: dropped 22.67% in 2021, then surged 509.51% in 2023.
  • A 5-year view of Work In Process shows it stood at $160.6 million in 2021, then rose by 27.02% to $204.0 million in 2022, then increased by 11.76% to $228.0 million in 2023, then decreased by 7.02% to $212.0 million in 2024, then decreased by 5.38% to $200.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Work In Process were $200.6 million in Q4 2025, $210.9 million in Q3 2025, and $215.2 million in Q2 2025.